𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy

✍ Scribed by C. Kollmannsberger; F. Mayer; M. Kuczyk; L. Kanz; C. Bokemeyer


Publisher
Springer-Verlag
Year
2001
Tongue
English
Weight
89 KB
Volume
19
Category
Article
ISSN
0724-4983

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


High-dose salvage chemotherapy. Germ-cel
✍ Oliver Rick; Wolfgang Siegert; JΓΆrg Beyer πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 65 KB πŸ‘ 2 views

During the past 10 years, high-dose chemotherapy (HDCT) has emerged as a feasible and curative treatment option for patients with multiply relapsed and/or refractory germ-cell tumors. Increasing experience and the results from clincial trials have helped to optimize the application of HDCT and to de

High-dose chemotherapy with hematopoieti
✍ A. FlΓ©chon; P. Biron; J.P. Droz πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 105 KB πŸ‘ 2 views

## Germ -cell tumors (GCTs) are very chemosensitive and highly curable cancers. For the small proportion of patients who fail conventional chemotherapy (CT), high-dose CT (HDCT) was introduced in France and elsewhere in 1982-1984. We report here on the French experience with HDCT in GCTs. At the C

Salvage high-dose chemotherapy in patien
✍ Giovanni Rosti; Ugo De Giorgi; Roberto Salvioni; Giorgio Papiani; Loretta Sebast πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 85 KB

## Abstract ## BACKGROUND High‐dose chemotherapy (HDCT) followed by hematopoietic stem cell support (HSCS) potentially may be curative in patients with germ cell tumor (GCT) who develop recurrent tumors or who have an inadequate response after receiving standard‐dose chemotherapy. The authors repo